Page 1256 - Small Animal Clinical Nutrition 5th Edition
P. 1256
1308 SMALL ANIMAL CLINICAL NUTRITION
in dogs and cats, 982 Neuter
in rabbits, 1219f, 1223 effect on energy requirement, 15b, 61t, 64-65, 258
in rodents, 1226, 1228 relationship to obesity, 258, 258f, 374t, 375, 511-512
VetBooks.ir Manganese, 108t, 120 NFE (See Nitrogen-free extract)
Materia alba, 983-984
Niacin, function, metabolism and sources, 133-134
MCT (See Medium-chain triglycerides) canine blood levels, 132t
Meal-restricted feeding (See also Food-restricted meal feed- feline blood levels, 132t
ing), 268t, 270t, 279t, 683-684 requirements/deficiencies/excesses, 124t
Meat and bone meal, 89t, 94t, 174t, 210b Nitrogen balance, 86, 92, 263, 276, 445, 483, 588, 782, 787b,
Meat byproducts, 197 1150, 1171, 1180
Medium-chain triglycerides, 97b, 338-339, 465-467, 470t, Nitrogen-free extract (NFE) (See also Carbohydrates), 49, 51f
482b, 1079, 1080b, 1081t, 1137, 1170, 1291a Non-insulin-dependent diabetes mellitus (NIDDM), feeding
Megacolon, in cats (See plan for, 567-570
Constipation/Obstipation/Megacolon) Nucleotides, use in hospitalized patients, 456
Megaesophagus (See Pharyngeal and esophageal disorders) Nutrient-drug interactions
Melamine toxicosis, 247-249c ACE inhibitors and potassium, 753-754
Metabolic acidosis, in chronic kidney disease, 774t, 779, 780t, cardiac glycosides and electrolytes, 754-755
783b, 787b, 793-794 diuretics and magnesium, 751-753
Metabolic bone disease (See Hyperparathyroidism) diuretics and potassium, 751-753
Metabolic yield (exercise), 329b Nutrients
Metabolizable energy (ME), 53-66, 55f conditionally essential, 68, 80b, 82, 83t, 84t, 93, 94, 123
Metallothionein, 109, 118-119, 645, 680, 1174, 1174f, 1190- definition of, 49
1192c drug interactions with, 1205-1207, 1205t
Methionine, 84t, 86, 89t, 90t, 92, 94t, 123, 124t, 138, 154, of concern (as part of key nutritional factors), 8
367, 367t, 371-372b, 598, 648, 1164b, 1181b, 1222t, 1227t, Nutrigenomics, 43-48
1260t glossary, 44t
Microminerals, 107, 117-122 canine and feline genomes, 47-48, 47b, 48b
Micronutrients: Minerals and vitamins, 107-148 Nutrition of reptiles, 1237-1254
Milk
nutritional composition, canine, 283t, 307t, 419t O
nutritional composition, feline, 283t, 419t Oats, 71, 72, 81, 86, 172
Milk replacers Obesity, 499-542
nutritional composition, canine, 306t assessment techniques for, 503-520, 504b
nutritional composition, feline, 424t body condition score, 504-507, 506t, 508b, 527b, 528t,
Minerals 531b
affects of fiber on, 79, 79t, 81, 514 morphometric measurements, 507, 536-537c, 537-538c,
availability of, 111-112 539-540c
definition of, 107 relative body weight, 501
functions of, 107-109,108t cardiovascular consequences of, 502, 734-735
interactions of, 110-111, 109f clinical importance of, 501-503
skin and hair disorders, 641, 645f, 645-648, 646t commercial foods for management of, 524t, 525t, 526t,
Moist pet food, (See also Canned [moist] pet food), 158-159, 533t, 534t
184-188, 185f, 186f, 187f diseases associated with, 502t
Moisture content, of pet food, 11b, 158-159, 169, 195, 198 drugs for, 533b
Morphometric measurements, in obesity, 507, 536-537c, 537- effects on drug metabolism, 1207
538c, 539-540c exercise for management of, 510b, 511, 521b
Muscle (See Skeletal muscle) feeding plans for patients with, 519-534
Musculoskeletal disorders (See Developmental orthopedic calculated time for weight loss, 532b
disease, Osteoarthritis) food dose calculation
Mycotoxins, in food, 230t, 233-234, 241c, 245-246c, 269b, for weight loss, 528t, 529f
for weight maintenance, 530f, 535t
N prevention of weight gain, 530-535, 535t
N-3 fatty acids (See Fatty acids) health risks of, 501-503, 502t
N-6 fatty acids (See Fatty acids) key nutritional factors for patients with, 512-519, 512t
Nasoesophageal feeding tubes, 458-459, 460-461b monitoring response to treatment, 531b
National Research Council (NRC), 8, 192-193, 192t predisposed breeds, 510
Neoplasia (See Cancer) prevalence in cats, 501
Nephrocalcin, 817, 818, 860-861, 872, 942 prevalence in dogs, 501
Nephrocalcinosis, 777f, 788, 878t regulatory definitions of, 513b
Nephrolithiasis, 819, 874-875 relationship to diabetes mellitus in cats, 560t, 562-563
Nephroliths, mineral composition of, 829t relationship to gender, age and gonadectomy, 511
Nephrotoxicity, drugs that cause, 768, 1027, 1202 risk factors for, 509-512